Cuorips Inc. (4894.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−36.0x

Market Cap

JPY 43.68B

MomentumView details →

1D Return

−2.39%

YTD Return

−10.95%

RSI (14)

53.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−36.0x

Market Cap

JPY 43.68B

RSI (14)

53.0

MomentumView details →

1D Return

−2.39%

YTD Return

−10.95%

ProfitabilityView details →

Gross Margin

47.26%

Net Margin

−214.89%

EBITDA Margin

−144.19%

ROE (TTM)

−15.21%

ROA (TTM)

−14.67%

Asset Turnover

0.07x

GrowthView details →

Revenue YoY

+947.06%

EPS YoY

+0.41%

FCF YoY

—

Revenue CAGR 3Y

+660.87%

EPS CAGR 3Y

+6.22%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

37.06x

Quick Ratio

36.81x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

356.00M

Net Income (TTM)

−765.00M

Op. CF (TTM)

—

Next earningsNov 12, 2026 →

Latest newsMore news →

The Central Social Insurance Medical Council (Chuikyo) approved the insurance reimbursement price for Qualips' iPS cell-derived myocardial cell sheet 'Reheart'.37d ago

Similar companies

Fuji Pharma Co.,Ltd.4554.T Heartseed Inc.219A.T Daito Pharmaceutical Co.,Ltd.4577.T SEIKAGAKU CORPORATION4548.T TAUNS Laboratories,Inc.197A.T MIZUHO MEDY CO.,LTD.4595.T Find similar companies →

Latest newsMore news →

The Central Social Insurance Medical Council (Chuikyo) approved the insurance reimbursement price for Qualips' iPS cell-derived myocardial cell sheet 'Reheart'.37d ago